I completely agree with the previous poster on the sell off today. This was clearly the action of a large enough shareholder to affect the price with the sell - it shook out many retail investors who, like me, have been riding the uptick on the price for weeks. I didn't sell, as I expect NLNK to be at $40 or more in 6-12 months. This company represents the future for cancer care, until finally, perhaps in 20 years, real cures are found. NLNK represents the state of the art knowledge on immunotherapy, along with a couple dozen other companies in this area. As investors, we get to take part in game changing therapies by investing in these companies today, while reaping the rewards. It's like investing in Merck or Pfizer many years ago. I may be wrong, but I suspect NLNK to go up tomorrow as other institutional buyers snap up the 12% discount!